In the case of obesity, which often coexists with metabolic syndrome and diabetes, lycopene has shown potential to reduce inflammation, improve insulin sensitivity, and reduce fatty liver disease in animal studies. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.